Orion HealthCorp, Inc. v. The United States of America, Department of Treasu

CourtUnited States Bankruptcy Court, E.D. New York
DecidedDecember 6, 2024
Docket8-18-08048
StatusUnknown

This text of Orion HealthCorp, Inc. v. The United States of America, Department of Treasu (Orion HealthCorp, Inc. v. The United States of America, Department of Treasu) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Orion HealthCorp, Inc. v. The United States of America, Department of Treasu, (N.Y. 2024).

Opinion

UNITED STATES BANKRUPTCY COURT EASTERN DISTRICT OF NEW YORK

In re: Chapter 11 Case Nos. 18-71748-67 (AST) Orion HealthCorp, Inc. et al., Case No. 18-71789 (AST) Debtors. Case No. 18-74545 (AST) (Jointly Administered) Howard M. Ehrenberg in his capacity as Liquidating Trustee of Orion Healthcorp, Inc., et al. Plaintiff, Adv. Pro. No. 18-08048 (AST) v. United States of America, Department of Treasury, Internal Revenue Service, Defendant.

DECISION AND ORDER ABSTAINING FROM REMAINDER OF ADVERSARY PROCEEDING

PROCEDURAL BACKGROUND On March 29, 2018, various chapter 11 debtors1, as plaintiffs (“Plaintiff Debtors”), filed a complaint commencing this adversary proceeding (the “Adversary Proceeding”) [dkt. item 1]. Plaintiff Debtors named a multitude of non-debtor parties as defendants in the original complaint, as well as the United States of America, Department of Treasury, Internal Revenue Service (“IRS”). Each of the non-debtor individual and/or corporate Non-IRS defendants were former

1 Debtors in these chapter 11 cases, along with the last four digits of each Debtor’s federal tax identification number, are: Orion Healthcorp, Inc. (7246); Constellation Healthcare Technologies, Inc. (0135); NEMS Acquisition, LLC (7378); Northeast Medical Solutions, LLC (2703); NEMS West Virginia, LLC (unknown); Physicians Practice Plus Holdings, LLC (6100); Physicians Practice Plus, LLC (4122); Medical Billing Services, Inc. (2971); Rand Medical Billing, Inc. (7887); RMI Physician Services Corporation (7239); Western Skies Practice Management, Inc. (1904); Integrated Physician Solutions, Inc. (0543); NYNM Acquisition, LLC (unknown) Northstar FHA, LLC (unknown); Northstar First Health, LLC (unknown); Vachette Business Services, Ltd. (4672); Phoenix Health, LLC (0856); MDRX Medical Billing, LLC (5410); VEGA Medical Professionals, LLC (1055); Allegiance Consulting Associates, LLC (7291); Allegiance Billing & Consulting, LLC (7141); New York Network Management, LLC (7168) (collectively, “Debtors”). shareholders of Debtor Constellation Healthcare Technologies, Inc. (“CHT”). On June 24, 2019, Howard M. Ehrenberg in his capacity as Liquidating Trustee of Debtors (the “Trustee”) filed a first amended complaint [dkt. item 117]. On March 12, 2020, the Trustee filed a second amended complaint (the “Second Amended Complaint”) [dkt. item 295].

Over the course of this litigation, the Trustee has settled with, obtained judgments against and/or dismissed from this action the many numerous non-debtor shareholder defendants. The IRS remains the only defendant in the Adversary Proceeding. On March 20, 2024, the Trustee filed a third amended complaint (the “Third Amended Complaint”) [dkt. item 606] which asserted claims only against the IRS and removed all other defendants. On May 3, 2024, the IRS filed a motion to dismiss the Adversary Proceeding (the “Dismissal Motion”) [dkt. items 612, 613]. On June 25, 2024, the Trustee filed opposition to the Dismissal Motion (the “Dismissal

Opposition”) [dkt. item 617]. On July 15, 2024, the IRS submitted its reply to the Dismissal Opposition and in further support of its Dismissal Motion [dkt. item 618]. On October 1, 2024, the Court entered an Order to Show Cause For Abstention (the “Order to Show Cause”) [dkt. item 621] directing the parties to demonstrate why this Court should or should not mandatorily or permissively abstain from hearing this Adversary Proceeding pursuant to 28 U.S.C. § 1334(c)(1) or (c)(2). The Order to Show Cause also gave the parties an opportunity to move to withdraw the reference of the Adversary Proceeding to the District Court. Neither the Trustee nor the IRS has moved to withdraw the reference. On October 25, 2024, the IRS responded to the Order to Show Cause, reiterating its request to dismiss this Adversary Proceeding for the reasons set forth in the Dismissal Motion, but otherwise seeking that this Court permissively abstain from hearing these matters [dkt. item 625]. On October 25, 2024, the Trustee filed a memorandum of law in opposition to the Order to Show Cause and requested that this Court neither mandatorily nor permissively abstain from

hearing the Adversary Proceeding [dkt. item 627]. On November 12, 2024, the IRS and the Trustee both submitted reply briefs in further support of their responses to the Order to Show Cause [dkt. items 628, 629]. For the reasons to follow, the Court has decided to permissively abstain from hearing the remainder of this Adversary Proceeding. RELEVANT FACTUAL BACKGROUND Pursuant to the Third Amended Complaint, the Trustee seeks to recover approximately $10,435,097.13 of payments made on behalf of shareholders of CHT to the IRS (the “IRS Funds”). Third Am. Comp. ¶ 9. However, the IRS Funds are not monies that CHT or any of the other

Debtors themselves had a right to recover as overpayments of tax liabilities. The complex factual background of this case relates to a “go-private” merger transaction (the “Merger”) which took place between CHT Holdco, LLC (“CHT Holdco”) and CHT. Third Am. Comp. ¶ 1. The Merger closed on or about January 30, 2017 (the “Closing Date”). Id. ¶ 79. Prior to the Merger, CHT’s shares were publicly traded on the London Stock Exchange’s Alternative Investments Market. Id. ¶ 53. Through the Merger, CHT Holdco acquired 100% of the issued and outstanding shares of CHT. Id. ¶ 54. There has been a great deal of litigation concerning the Merger which has taken place before this Court and others over the past several years. The proceeds of the Merger were paid to non-debtor individuals and/or entities. According to the Third Amended Complaint, a total of $212,502,269.25 in proceeds (the “Merger Proceeds”) were paid out in connection with the Merger. Third Am. Comp. ¶ 6. Approximately $100 million of the Merger Proceeds was paid to Parmar Shareholder Entities (as defined in the Third Amended Complaint). Id. ¶¶ 2, 6. Other CHT shareholders who were previously named in the Adversary

Proceeding as defendants in the Second Amended Complaint, received the remaining approximate $120 million of the Merger Proceeds as follows: (a) approximately $80.3 million in cash, and (b) $13.6 million in promissory notes in exchange for their CHT shares. Id. ¶ 7. Bank of America, N.A. (as Administrative Agent, L/C Issuer) and Swingline Lender (collectively, the “Lenders”) loaned $130 million to fund the Merger Proceeds, along with an equity contribution of $82,502,160.25 from CC Capital CC Holdco LLC (“CC Holdco”) into a CC Holdco bank account maintained by JPMorgan Chase (the “CC Holdco Bank Account”). Id. ¶¶ 8, 82-83. CHT, other Debtors and certain non-debtors jointly and severally guaranteed the debt owed to the Lenders, gave first priority liens in all their properties, and pledged 100% of the equity interest in each of

their subsidiaries. Id. ¶¶ 9, 84-85. As of the Closing Date, the CC Holdco Bank Account held the full $212,502,269.25 of Merger Proceeds. Id. ¶ 86. On the Closing Date, $177,154,981.43 in Merger Proceeds was transferred from the CC Holdco Bank Account to an account at the Royal Bank of Scotland, plc. maintained by Capita Registrars Limited (“Capita”), the exchange agent for the Merger. Id. ¶ 88. The remaining $35,347,287.82 was held in the CC Holdco Bank Account. Id. Capita and CC Holdco ultimately disbursed the Merger Proceeds to CHT shareholders and/or otherwise used the Merger Proceeds to pay fees and costs incurred in connection with the Merger as discussed above. Id. ¶¶ 7, 8, 88. At the time of the Merger, Capita retained $10,435,097.13 of these CHT shareholder payments (i.e., the IRS Funds). Id. ¶ 90.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Orion HealthCorp, Inc. v. The United States of America, Department of Treasu, Counsel Stack Legal Research, https://law.counselstack.com/opinion/orion-healthcorp-inc-v-the-united-states-of-america-department-of-nyeb-2024.